CEO And CFO Both Buy Big

This Is An Undeniable Opportunity to Profit Massively

Hey Trader, My lead analyst, Steve Place, just made a new video about a hot biotech stock that could be ready to pop. This company's developing a MUCH cheaper alternative to a $10-$15k voluntary medical procedure. Based on my team's research, it's potentially just as effective.  Exciting stuff, but that alone isn't why we're looking at the company. After all, someone could develop a drug or medical treatment that ends up failing. No… We're looking at it because the CEO and CFO that both bought tons of stock out of nowhere. They both bought the exact same number of shares — just over 30k — at the exact same time about 12 days ago.  Altogether, each one dropped $99,997 into the stock. Not surprisingly, it's already up a decent amount from when they invested. It's still cheap enough to be a buy, but who knows how long that'll last. Check out the video for the full details on this biotech opportunity...   Dustin Pass Editor, Insider Report   In Case You Missed It 1. Some Great Opportunities in the Energy Sector 2. LOL: This Insider Tried to Hide From Us 3. Watchlist Wednesday: Don't Miss These 12 Names in This Hot Sector

Market Traders Daily Director of Client Services 888-228-2376

Disclaimer: Futures, forex, stock, and options trading are not appropriate for all traders. There is a substantial risk of loss associated with trading these markets. Losses can and will occur. No system or methodology has ever been developed that can ensure returns or against losses. No representation or implication is being made that using any of these methodologies or systems will generate returns or ensure against losses.   Global Profits System International 14422 Shoreside Way STE 104-153 Winter Garden Florida 34787 United States click here to unsubscribe